Page 24 - Martin Shkreli Case Study

Bloomberg: TV Appearances (4)

"If there was a company that was
selling an Aston Martin at the price of a
bicycle, and we buy that company and

we ask to charge Toyota prices, I don’t think that that should be a
crime".

Martin Shkreli

In late November Shkreli appeared on Bloomberg TV. On the show, he
claimed he didn't pay attention to the stock market at all also that he saw
"no reason or need" to reverse merger Turing Pharmaceuticals and
KaloBios. Further he said they were in talks for three separate
acquisitions in rare diseases:

One: FDA approved drug and

Two: not-yet approved drugs.

George Scangos, CEO of biotechnology giant Biogen Inc., went further
saying in an interview,

“Turing is to a research-based company like a loan shark is to a
legitimate bank.”

http://www.bloomberg.com/news/articles/2015-09-25/old-drug-price-hike-perversion-
of-the-system-biogen-ceo-says